CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX

Transcription

1 A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety, 20 Computerized Decision Aid, 53 Criminality, 9 Defecation Disorders, 64 Edivoxetine, 28 Guanfacine Dose Timing, 51 Lifestyle Factors, 4 Lisdexamfetamine for Emotional Control Deficits, 65 Lisdexamfetamine and Quality of Life, 44 Lisdexamfetamine Vs. Atomoxetine, 59 Medications and Injury, 37 Methylphenidate Extended-Release Liquid, 10 NEBA System, 37 Neural Mechanisms in Chronic Irritability, 61 Nonpharmacological Treatments, 17 Obesity, 33 Parent Behavior Training, 29 Parent Preferences, Goals, 58 Solar Intensity and Prevalence, 19 Stimulant-Associated Cough, 46 Stimulants and Substance Abuse, 41 adverse effects Antipsychotic Rhabdomyolysis, 2 Aripiprazole Prolactin Suppression, 34 Risperidone Iron Deficiency, 22 Stimulant-Associated Cough, 46 aggression Amantadine After Brain Injury, 21 Clozapine in Conduct Disorder, 16

2 agitation Amantadine After Brain Injury, 21 agoraphobia Bullying, 21 amantadine In Pediatric Psychiatry, 21 amphetamine-dextroamphetamine Cough, 46 amphetamines Cancer Risk, 31 antidepressants. See also specific drugs Cancer Risk, 31 Substance Use Disorders and Bipolar Disorder, 62 Suicidality, 45 Tolerability, 55 antiparkinsonian drugs antipsychotics. See also specific drugs Amantadine for Weight Gain, 21 Cancer Risk, 31 Diabetes Risk, 49 Rhabdomyolysis, 2 anxiety disorders. See also specific disorders Adjunctive Attention Modification Training, 40 Bullying, 21 CBT Efficacy with Comorbid ADHD, 20 Guanfacine for Trauma-Related Stress, 39 Neural Mechanisms in Chronic Irritability, 61 Treating Preschoolers, 25 anxiolytics aripiprazole Diabetes Risk, 49 Prolactin Suppression, 34 Tourette Syndrome, 68 aspirin Schizophrenia, 67

3 atomoxetine ADHD Medications and Injury, 37 Growth Effects, 64 Safety and Efficacy in ADHD, 23 Vs. Lisdexamfetamine, 59 attention modification training Anxiety, 40 avoidance Guanfacine for Trauma-Related Stress, 39 autism spectrum disorders Amantadine, 21 Complementary and Alternative Treatments, 8 N-acetylcysteine, 46 Oxytocin Intranasal Spray, 35, 47 Prenatal Folic Acid Exposure, 15 Prenatal Valproate Exposure, 26 B behavioral activation behavioral inhibition Preschool Anxiety and Depression, 25 behavioral problems Maternal Smoking and Conduct Problems, 57 beta blockers bipolar disorder Intranasal Ketamine, 3 Maternal Smoking, 71 Psychosocial Treatments, 50 Substance Use Disorders, 62 brain wave assessment NEBA System for ADHD Diagnostics, 37 bullying Young Adult Consequences, 21 C caffeine Violence and Conduct Disorders, 15 cancer ADHD Medications, 31 chelation therapy

4 clozapine Resistant Conduct Disorder, 16 coffee Caffeine and Violence, 15 cognitive-behavioral prevention Recurrent Depression, 68 cognitive behavioral therapy (CBT) Anxiety Comorbid with ADHD, 20 Bipolar Disorder, 50 Preschool Anxiety and Depression, 25 Substance Abuse in Conduct Disorder, 1 cognitive bias modification training Social Anxiety, 35 cognitive training ADHD, 17 cola Caffeine and Violence, 15 complementary and alternative treatments conduct disorders Caffeine Intake, 15 Clozapine, 16 Delinquent Activities Scale, 70 Substance Use, 1, 32 conduct problems Maternal Smoking During Pregnancy, 57 constipation ADHD, 64 criminality ADHD Medication, 9 cyproheptadine cytochrome P450 Guanfacine Pharmacokinetics, 27 D D-cycloserine Resistant OCD, 38 defecation disorders ADHD, 64 Delinquent Activities Scale Conduct Disorder, 70

5 depression Amantadine, 21 Bullying, 21 Escitalopram, 58 Treating Preschoolers, 25 depression, maternal Offspring Effects, 63 depression, recurrent Cognitive-Behavioral Prevention, 68 diabetes risk Antipsychotics, 49 dialectical behavior therapy Bipolar Disorder, 50 dietary restrictions ADHD, 17 disruptive behavior disorders Psychosocial Treatments, 7 disruptive mood dysregulation disorder Prevalence, 14 dissociative effects Intranasal Ketamine, 3 E edivoxetine ADHD, 28 electroconvulsive therapy emotional control Lisdexamfetamine in ADHD, 65 energy drinks Caffeine and Violence, 15 escitalopram Extended Depression Treatment, 58 exposure and response prevention therapy Adjunctive D-Cycloserine, 38 F Family-Focused Treatment for Adolescents Bipolar Disorder, 50 family intervention Adolescent Suicidality, 43 family psychoeducation Bipolar Disorder, 50

6 fatty acids ADHD, 5, 17 fear-of-harm phenotype Intranasal Ketamine in Bipolar Disorder, 3 fecal incontinence ADHD, 64 fetal exposure Folic Acid and Autism, 15 Maternal Smoking and Bipolar Disorder, 71 Maternal Smoking and Conduct Problems, 57 Valproate and Autism, 26 fluoxetine Predictors of Nonresponse in Social Anxiety, 10 fluvoxamine Predictors of Nonresponse in Social Anxiety, 10 folic acid, 15 G generalized anxiety disorder Bullying, 21 Guanfacine for Trauma-Related Stress, 39 Preschoolers, 25 growth ADHD Medication Effects, 64 guanfacine Morning Vs. Evening Dosing, 51 Pharmacokinetics in ADHD, 27 Trauma-Related Stress, 39 H L haloperidol Rhabdomyolysis, 2 hyperactivity hyperarousal Guanfacine for Trauma-Related Stress, 39 immune activation Adjunctive Aspirin in Schizophrenia, 67 impulsivity

7 inflammation Adjunctive Aspirin in Schizophrenia, 67 insomnia integrated behavior therapy Selective Mutism, 52 iron deficiency Risperidone, 22 iron supplementation irritability Neural Mechanisms, 61 ketamine, intranasal Bipolar Disorder, 3 lisdexamfetamine dimesylate Emotional Control in ADHD, 65 Quality of Life in ADHD, 44 Vs. Atomoxetine, 59 lithium Substance Use Disorders and Bipolar Disorder, 62 M magnesium manic symptoms massage therapy melatonin mental health awareness Campaigns, 48 metabolic syndrome metformin methylphenidate ADHD Medications and Injury, 37 Cancer Risk, 31 Extended-Release Liquid, 10 Growth Effects, 64

8 mood stabilizers motivational interviewing Substance Abuse in Conduct Disorder, 1 multifamily psychoeducational psychotherapy Bipolar Disorder, 50 multisystemic therapy Substance Abuse in Conduct Disorder, 1 multivitamins/minerals N N-acetylcysteine Autism, 46 naltrexone Skin Picking, 4 negative mood Disruptive Mood Dysregulation Disorder, 14 neural mechanisms Chronic Irritability, 61 neurofeedback ADHD, 17 neuroleptic malignant syndrome Antipsychotics and Rhabdomyolysis, 2 neuropsychiatric EEG-based assessment aid (NEBA) system ADHD Diagnostics, 37 nonsteroidal anti-inflammatory drugs (NSAIDs) Adjunctive Aspirin in Schizophrenia, 67 O obesity ADHD, 4, 33, 64 obsessive-compulsive disorder Adjunctive D-Cycloserine, 38 Preschoolers, 25 Sexual Obsessions, 27 OK2TALK Mental Health Awareness, 48 olanzapine Diabetes Risk, 49 Rhabdomyolysis, 2 oppositional defiant disorder Neural Mechanisms in Chronic Irritability, 61

9 Substance Use Disorders and Bipolar Disorder, 62 overarousal symptoms Guanfacine for Trauma-Related Stress, 39 oxidative stress N-acetylcysteine in Autism, 46 oxytocin Intranasal Spray for Autism, 35, 47 P paliperidone panic disorder Bullying, 21 Substance Use Disorders and Bipolar Disorder, 62 parent behavior training Preschool ADHD, 29 Parent-Child Interaction Therapy Preschool Anxiety and Depression, 25 phobias One-Session Therapy, 50 Preschoolers, 25 polyunsaturated fatty acids (PUFAs) ADHD, 5 posttraumatic stress Acceptance and Commitment Therapy, 69 posttraumatic stress disorder (PTSD) Preschoolers, 25 practice parameter Schizophrenia, 56 preschool children ADHD, 29 Anxiety and Depression, 25 probiotics prolactin Aripiprazole Effects, 34 Risperidone Effects, 22 psychoeducation Substance Abuse in Conduct Disorder, 1 psychosocial treatments ADHD, 17 Bipolar Disorder, 50 Disruptive Behavior, 7

10 psychotherapy Q, R quality of life Lisdexamfetamine in ADHD, 44 quetiapine reactive attachment disorder Childhood Maltreatment, 11 reexperiencing Guanfacine for Trauma-Related Stress, 39 Resourceful Adolescent Parent Program Adolescent Suicidality, 43 rhabdomyolysis Antipsychotics, 2 risperidone Diabetes Risk, 49 Iron Deficiency and Prolactin Effects, 22 Rhabdomyolysis, 2 S schizophrenia Adjunctive Aspirin, 67 Practice Parameter, 56 selective mutism Integrated Behavior Therapy, 52 selective serotonin reuptake inhibitors (SSRIs). See also specific drugs Predictors of Nonresponse in Social Anxiety, 10 self-harm High-Risk Self-Cutting, 13 separation anxiety disorder Preschoolers, 25 sertraline Predictors of Nonresponse in Social Anxiety, 10 sexual obsessions OCD, 27 skin picking Naltrexone, 4 smoking During Pregnancy and Bipolar Disorder, 71 During Pregnancy and Conduct Problems, 57

11 social anxiety disorder Cognitive Bias Modification Training, 35 Predictors of SSRI Nonresponse, 10 stimulants. See also specific drugs Amphetamine-Dextroamphetamine Cough, 46 Substance Abuse in ADHD, 41 substance use disorders Bipolar Disorder, 62 In Conduct Disorder, 32 Multisystemic Therapy in Conduct Disorder, 1 Stimulant Medications, 41 suicidality Antidepressants, 45 Bullying, 21 Family Intervention, 43 High-Risk Self-Cutting, 13 sunlight ADHD Prevalence, 19 T V tantrums Disruptive Mood Dysregulation Disorder, 14 tea Caffeine and Violence, 15 tics Aripiprazole for Tics, 68 Tourette syndrome Aripiprazole, 68 traumatic brain injury Amantadine, 21 traumatic stress Guanfacine, 39 twelve-step programs Substance Abuse in Conduct Disorder, 1 valproate Prenatal Exposure and Autism, 26 violence Caffeine Intake, 15 vitamin B6 vitamin C

12 W Z watchful waiting Preschool Anxiety and Depression, 25 weight ADHD Medication Effects, 64 ziprasidone